Publications by authors named "Lijie Xing"

Claim this Profile
C
Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma.
Dan Liu, Haichen Wei, Yanran Hu, Hui Wang, Ping Li, Lijie Xing

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymerase-based DNA reactions for molecularly computing cancerous diagnostic valences of multiple miRNAs.
Yumin Yan, Hongyang Zhao, Lijie Xing, Ye Ouyang, Linghao Zhang

J Nanobiotechnology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Transformation of natural killer-cell large granular lymphocytic leukemia to aggressive natural killer cell leukemia.
Wen Wang, Ke Lu, Lijie Xing, Zengjun Li

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-cell lymphoma with central nervous system involvement and elevated interleukin-10 levels in the cerebrospinal fluid: A case report.
Xin Wang, Haichen Wei, Dan Liu, Hui Wang, Zengjun Li, Lijie Xing

Precis Radiat Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Determination of 32 Polyphenolic Compounds in Berries via HPLC-MS/MS.
Yuan Wang, Lijie Xing, Jinlei Zhang, Yongfa Chen, Shiling Lu

Molecules· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Volatile and Non-Volatile Components of Dried Chili Pepper ( L.).
Wenqi Li, Yuan Wang, Lijie Xing, Wensheng Song, Shiling Lu

Foods· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study.
Xia Yin, Qiang He, Dan Liu, Linna Xie, Hui Wang, Lijie Xing

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma.
Dan Liu, Xia Yin, Hui Wang, Lijie Xing, Ping Li

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms.
Liying Yang, Mengdi Wu, Hao Yang, Xiaorong Sun, Lijie Xing, Ligang Xing

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment.
Ke Lu, Wen Wang, Yuntong Liu, Chao Xie, Jiye Liu, Lijie Xing

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.
Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous determination of triazole fungicides in animal-origin food by ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
Lijie Xing, Yang Liu, Wenqi Li, Liangjun Zou, Yuan Wang

Food Chem X· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy.
Lijie Xing, Yuntong Liu, Jiye Liu

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of high-throughput drug sensitivity test.
Lijie Xing, Hui Wang, Dan Liu, Qiang He, Zengjun Li

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
Hailin Chen, Tengteng Yu, Liang Lin, Lijie Xing, Shih-Feng Cho

Blood Cancer J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.
Lijie Xing, Qiang He, Linna Xie, Hui Wang, Zengjun Li

Haematologica· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the Quality of Frozen Lamb by Microencapsulated Apple Polyphenols: Effects on Cathepsin Activity, Texture, and Protein Oxidation Stability.
Yuanyuan Zhong, Yangming Liu, Lijie Xing, Mou Zhao, Wenxia Wu

Foods· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.
Shih-Feng Cho, Lijie Xing, Kenneth C Anderson, Yu-Tzu Tai

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression.
Lijie Xing, Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment.
Jiye Liu, Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou

Sci Adv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma.
Liang Lin, Shih-Feng Cho, Lijie Xing, Kenneth Wen, Yuyin Li

Leukemia· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo.
Tengteng Yu, Bharat Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan

Blood Cancer J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models.
Shih-Feng Cho, Liang Lin, Lijie Xing, Yuyin Li, Kenneth Wen

Blood Adv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma.
Shih-Feng Cho, Liang Lin, Lijie Xing, Yuyin Li, Tengteng Yu

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The yin and yang functions of extracellular ATP and adenosine in tumor immunity.
Li-Li Feng, Yi-Qing Cai, Ming-Chen Zhu, Li-Jie Xing, Xin Wang

Cancer Cell Int· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis